0001209191-12-027015.txt : 20120509
0001209191-12-027015.hdr.sgml : 20120509
20120509163605
ACCESSION NUMBER: 0001209191-12-027015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120507
FILED AS OF DATE: 20120509
DATE AS OF CHANGE: 20120509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Lisa
CENTRAL INDEX KEY: 0001349077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12826243
MAIL ADDRESS:
STREET 1: 125 SPRING STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-05-07
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001349077
Kelly Lisa
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Human Resources
Common Stock
2012-05-07
4
M
0
28593
32.16
A
57168
D
Common Stock
2012-05-07
4
M
0
3813
32.16
A
60981
D
Common Stock
2012-05-07
4
S
0
16242
55.00
D
44739
D
Common Stock
2012-05-07
4
S
0
7187
52.13
D
37552
D
Common Stock
2012-05-07
4
S
0
14297
57.50
D
23255
D
Common Stock
1667
I
401(k)
Stock Option
32.16
2012-05-07
4
M
0
28593
0.00
D
2008-10-24
2018-07-23
Common Stock
28593
1907
D
Stock Option
18.93
2012-05-07
4
M
0
3813
0.00
D
2018-02-06
Common Stock
3813
0
D
Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Fully vested.
David T. Howton, Attorney-In-Fact
2012-05-09